Diagnosis of Helicobacter pylori infection: serology vs. urea breath test
Microbiology Spectrum · 2024
DOI: 10.1128/spectrum.01084-24 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Miguel Imperial und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Lab Medicine, University of British Columbia, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Helicobacter Infections, Breath Tests, Urea, Helicobacter pylori. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The objective of the study was to ascertain an optimal Helicobacter pylori diagnostic strategy using population-level laboratory data comparing the performance of serology against urea breath test (UBT). H. pylori diagnostic test results for serology and UBT from two laboratories over a 12-year period (2006–20017) were extracted, linked, and analyzed. A subset of this population underwent both methods of testing within days of each other, enabling a direct comparison of the two methods. The average prevalence of H. pylor i positivity was 21.3% by serology and 17.5% by UBT. There were 2,612 individuals who had serology performed first, followed by UBT within 14 days. For this subset, the sensitivity of serology compared with UBT was 96.5% with a specificity of 79.2%. The negative predictive value for serology was 98.4%. Contrary to various recent clinical guidelines, the data show that serology still has utility as a sensitive enough test to be used as an initial H. pylori screening test in a lower prevalence population. Negative serology can be used with confidence to rule out active infection, whereas a positive serology could be followed up with a UBT or a similar performing test such as stool antigen to differentiate active from past infection. For population-based diagnostic recommendations, such a strategy may be ideal since serology generally costs less than UBT and may be combined with a blood draw being done for other diagnostic tests. Continuing to offer serology increases options for patients and may provide economic benefits for single-payer health care systems or health maintenance organizations. IMPORTANCE This study compares the performance of serology with urea breath test in the diagnosis of Helicobacter pylori in a population-level data set and mimics a head-to-head direct comparison as the study population had both tests performed within 2 weeks of each other. This provides new information supporting the use of serology in a diagnostic algorithm. There are several instances where serology could be preferable to patients to rule out disease, despite some guidelines suggesting serology should not be used.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Lab Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
- BC Women's and Children's Hospital, Vancouver, British Columbia, Canada.
- Lifelabs, Surrey, British Columbia, Canada.
- Fraser Health Authority, Surrey, British Columbia, Canada.
- British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
ORCID-Profile: Miguel Imperial, Muhammad Morshed
Zitieren
APA
Imperial, M., Tan, K., Fjell, C., Chang, Y., Krajden, M., Kelly, M. T., & Morshed, M. (2024). Diagnosis of Helicobacter pylori infection: serology vs. urea breath test. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01084-24
Vancouver
Imperial M, Tan K, Fjell C, Chang Y, Krajden M, Kelly MT, et al. Diagnosis of Helicobacter pylori infection: serology vs. urea breath test. Microbiology Spectrum. 2024. doi:10.1128/spectrum.01084-24
BibTeX
@article{Imperial2024,
author = {Imperial, Miguel and Tan, Kennard and Fjell, Chris and Chang, Yin and Krajden, Mel and Kelly, Michael T and Morshed, Muhammad},
title = {Diagnosis of Helicobacter pylori infection: serology vs. urea breath test},
journal = {Microbiology Spectrum},
year = {2024},
doi = {10.1128/spectrum.01084-24}
}
EUVIMED